ICRA maintains stable outlook for Indian pharma companies
					Domestic pharma cos expected to grow at a CAGR of around 10-12 per cent between FY2019-2022
ICRA has maintained a stable…				
						Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.